Exploratory study of DPP-4 inhibitor on glycemic control and organ protection in type2 diabetic patients
Phase 4
- Conditions
- Type-2 diabetic patients (Type-2 diabetic patients with microalbuminuria or nephropathy)
- Registration Number
- JPRN-UMIN000012171
- Lead Sponsor
- Tokyo Jikei University School of Medicine Kashiwa Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)Type-1 diabetes millius 2)Serum creatinin level of more than 1.2mg/dL in male patients and 1.0mg/dL in female patients 3)Diabetic ketosis, diabetic coma or total coma within 6 months 4)Severe infectious disease, before or after surgery, and severe trauma 5)Occurrence of ischemic stroke, hemorrhagic stroke or TIA within 6 months 6)Moderate or severe heart failure (NYHE 3 or 4) 7)Patients who receive other DPP4 inhibitors during 3 month before starting study 8)Under treatment with insulin 9)Pregnant, lactating, possibly pregnant or planning to become pregnant women 10)Past medical history of hypersensitivity to linagliptin 11)Patients considered as inadequate by the principal investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method